Clinical Trial Update: Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA) [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial (NeoURANIA) is evaluating weekly utidelone with cisplatin for breast cancer and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Utidelone (utidelone)

Snippet

Sponsor: RenJi Hospital | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING